# Pre-emptive Scalp Infiltration with Triamcinolone Acetonide Plus Ropivacaine for Post-Craniotomy Pain in Children

> **NCT06779396** · PHASE4 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 128 (estimated)

## Conditions studied

- Pain
- Postoperative Children

## Interventions

- **DRUG:** The triamcinolone acetonide plus ropivacaine group
- **DRUG:** The ropivacaine group

## Key facts

- **NCT ID:** NCT06779396
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06779396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06779396, "Pre-emptive Scalp Infiltration with Triamcinolone Acetonide Plus Ropivacaine for Post-Craniotomy Pain in Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06779396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*